Also found in: Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.


n. mielosupresión, producción reducida de eritrocitos y de plaquetas en la médula ósea.
References in periodicals archive ?
Importantly, MRX-I has not caused myelosuppression, the key limiting side effect of currently available oxazolidinone drugs.
Myelosuppression is often a dose-limiting toxicity, with leucopenia being more common than thrombocytopenia or anaemia.
Unlike traditional cytotoxic agents, Erlotinib and Gefitinib do not typically cause myelosuppression, neuropathy, alopecia, or severe nausea.
Myelosuppression: Patients may experience grade 3-4 myelosuppression with some oral agents.
Hypersensitivity to dacarbazine and severe myelosuppression.
Because of myelosuppression, which was unexpected from chemotherapy, hyperbilirubinemia, hypertriglyceridemia, and hypofibrinogenemia, the patient was thought to have HPS.
Myelosuppression (decrease in the production of blood cells by the bone marrow) was the most common adverse reaction associated with satraplatin therapy, with 98.
No Myelosuppression or Alopecia in patients from PRECISION I (Barcelona)
All patients showed rapid and almost complete improvement of symptoms," without any adverse effects, pain, or myelosuppression.
Apart from the variability of myelosuppression, the compound demonstrated a superior safety profile in comparison to other cytotoxics.
This regimen is associated with considerable toxicity, including myelosuppression and neuropathy.